Schwartz Investment Counsel’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,400
| Closed | -$3M | – | 139 |
|
|
2024
Q1 | $3M | Hold |
34,400
| – | – | 0.11% | 90 |
|
|
2023
Q4 | $2.83M | Sell |
34,400
-280,000
| -89% | -$21.3M | 0.11% | 87 |
|
|
2023
Q3 | $24.6M | Sell |
314,400
-1,000
| -0.3% | -$83.7K | 1.05% | 39 |
|
|
2023
Q2 | $27.8M | Hold |
315,400
| – | – | 1.17% | 34 |
|
|
2023
Q1 | $25.4M | Sell |
315,400
-80,700
| -20% | -$6.58M | 1.11% | 36 |
|
|
2022
Q4 | $30.8M | Sell |
396,100
-30,119
| -7% | -$2.44M | 1.4% | 30 |
|
|
2022
Q3 | $34.4M | Sell |
426,219
-9,982
| -2% | -$897K | 1.77% | 18 |
|
|
2022
Q2 | $39.1M | Sell |
436,201
-94,091
| -18% | -$9.53M | 1.9% | 18 |
|
|
2022
Q1 | $58.8M | Buy |
530,292
+23,000
| +5% | +$2.43M | 2.47% | 12 |
|
|
2021
Q4 | $52.5M | Sell |
507,292
-162,200
| -24% | -$18.8M | 2.04% | 16 |
|
|
2021
Q3 | $83.9M | Hold |
669,492
| – | – | 3.45% | 5 |
|
|
2021
Q2 | $83.1M | Hold |
669,492
| – | – | 3.35% | 6 |
|
|
2021
Q1 | $79.1M | Sell |
669,492
-43
| -0% | -$5.04K | 3.43% | 6 |
|
|
2020
Q4 | $78.4M | Sell |
669,535
-24,286
| -4% | -$2.67M | 3.56% | 4 |
|
|
2020
Q3 | $72.1M | Sell |
693,821
-39
| -0% | -$3.92K | 3.64% | 4 |
|
|
2020
Q2 | $63.6M | Buy |
693,860
+44,596
| +7% | +$4.28M | 3.45% | 4 |
|
|
2020
Q1 | $58.6M | Buy |
649,264
+14,500
| +2% | +$1.54M | 3.89% | 2 |
|
|
2019
Q4 | $72M | Sell |
634,764
-11,500
| -2% | -$1.26M | 3.41% | 3 |
|
|
2019
Q3 | $70.2M | Sell |
646,264
-44,000
| -6% | -$4.59M | 3.57% | 2 |
|
|
2019
Q2 | $67.2M | Buy |
690,264
+4,000
| +0.6% | +$365K | 3.45% | 1 |
|
|
2019
Q1 | $62.5M | Sell |
686,264
-3,000
| -0.4% | -$269K | 3.34% | 1 |
|
|
2018
Q4 | $62.7M | Sell |
689,264
-2,500
| -0.4% | -$234K | 3.86% | 1 |
|
|
2018
Q3 | $68M | Hold |
691,764
| – | – | 3.62% | 1 |
|
|
2018
Q2 | $59.2M | Buy |
691,764
+73,000
| +12% | +$6.1M | 3.38% | 1 |
|
|
2018
Q1 | $49.6M | Buy |
618,764
+80,000
| +15% | +$6.6M | 2.93% | 6 |
|
|
2017
Q4 | $43.5M | Buy |
538,764
+4,857
| +0.9% | +$389K | 2.58% | 9 |
|
|
2017
Q3 | $41.5M | Buy |
533,907
+10,000
| +2% | +$830K | 2.6% | 9 |
|
|
2017
Q2 | $46.5M | Hold |
523,907
| – | – | 2.98% | 4 |
|
|
2017
Q1 | $42.2M | Buy |
523,907
+10,000
| +2% | +$781K | 2.76% | 7 |
|
|
2016
Q4 | $36.6M | Buy |
513,907
+43,000
| +9% | +$3.38M | 2.54% | 6 |
|
|
2016
Q3 | $40.7M | Sell |
470,907
-217
| -0% | -$18.9K | 2.9% | 2 |
|
|
2016
Q2 | $40.9M | Hold |
471,124
| – | – | 2.96% | 3 |
|
|
2016
Q1 | $35.3M | Sell |
471,124
-270
| -0.1% | -$20.3K | 2.65% | 5 |
|
|
2015
Q4 | $36.3M | Buy |
471,394
+14,000
| +3% | +$1.05M | 2.75% | 3 |
|
|
2015
Q3 | $30.6M | Buy |
457,394
+76,000
| +20% | +$5.6M | 2.38% | 4 |
|
|
2015
Q2 | $28.3M | Sell |
381,394
-5,216
| -1% | -$399K | 1.92% | 14 |
|
|
2015
Q1 | $30.2M | Buy |
386,610
+340,610
| +740% | +$25.8M | 2% | 10 |
|
|
2014
Q4 | $3.32M | Buy |
46,000
+6,000
| +15% | +$417K | 0.22% | 87 |
|
|
2014
Q3 | $2.48M | Hold |
40,000
| – | – | 0.18% | 91 |
|
|
2014
Q2 | $2.55M | Sell |
40,000
-1,000
| -2% | -$60.7K | 0.18% | 96 |
|
|
2014
Q1 | $2.52M | Sell |
41,000
-295,600
| -88% | -$17.2M | 0.19% | 96 |
|
|
2013
Q4 | $19.3M | Sell |
336,600
-12,900
| -4% | -$731K | 1.45% | 22 |
|
|
2013
Q3 | $18.6M | Buy |
349,500
+3,800
| +1% | +$204K | 1.58% | 16 |
|
|
2013
Q2 | $17.8M | Buy |
+345,700
| New | +$17.1M | 1.77% | 7 |
|
Other funds holding MDT
Schwartz Investment Counsel's MDT Position: Q2 2024 in Review
Schwartz Investment Counsel sold out of Medtronic (MDT) in Q2 2024, closing a stake of 34,400 shares — an estimated $3M sold.
Schwartz Investment Counsel first reported a position in MDT in Q2 2013 and held it in 44 quarters. The position peaked at $83.9M in Q3 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.
- Schwartz Investment Counsel reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
- Schwartz Investment Counsel sold 34,400 Medtronic shares in Q2 2024, an estimated $3M.
- Schwartz Investment Counsel first reported a position in Medtronic in Q2 2013 and held it in 44 quarters.
- Schwartz Investment Counsel's Medtronic position peaked at $83.9M in Q3 2021.
- 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.
Based on Schwartz Investment Counsel's 13F filing for Q2 2024, filed 24 Jul 2024.